Artery Research

In Press, Corrected Proof, Available Online: 4 May 2020

The European COST Action VascAgeNet Fostering Innovation – When Industry Comes to Science

Authors
Christopher C. Mayer1, *, , Rachel E. Climie2, 3, 4, Bernhard Hametner1, Rosa-Maria Bruno2, 5
1Center for Health & Bioresources, Biomedical Systems, AIT Austrian Institute of Technology GmbH, Giefinggasse 4, Vienna 1210, Austria
2INSERM U970 Paris-Centre de Recherche Cardiovasculaire (PARCC), Paris, France
3Sports Cardiology and Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Australia
4Blood Pressure Research Group, Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Hobart/Tasmania, Australia
5Department of Pharmacology, Université Paris Descartes – Université de Paris, Paris, France
*Corresponding author. Email: christopher.mayer@ait.ac.at
Corresponding Author
Christopher C. Mayer
Received 29 November 2019, Accepted 28 April 2020, Available Online 4 May 2020.
DOI
https://doi.org/10.2991/artres.k.200430.001How to use a DOI?
Keywords
COST action, VascAgeNet, vascular ageing, innovation
Abstract

VascAgeNet is a new European network which will join forces in order to refine, harmonize and promote the vascular ageing concept. It aims to bring innovations in cardiovascular research from bench to bedside and to establish assessment of vascular ageing in clinical practice. The interdisciplinary, inter-country and intersectional approach will enable all important players at the different stages of the innovation process to come together, as recommended in the triple or quadruple helix model of innovation, in order to guarantee best solutions. This is deemed necessary in order for economic and revolutionary solutions to be fit for wide-spread clinical use, especially in low-income and inclusiveness target countries. Thus, a clear case exists for a strong collaboration between science and industry, to foster innovations and breakthroughs in vascular ageing in order to improve clinical practice and to reduce the burden of cardiovascular diseases globally.

Copyright
© 2020 Association for Research into Arterial Structure and Physiology. Publishing services by Atlantis Press International B.V.
Open Access
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)
View full text (HTML)

Journal
Artery Research
Publication Date
2020/05
ISSN (Online)
1876-4401
ISSN (Print)
1872-9312
DOI
https://doi.org/10.2991/artres.k.200430.001How to use a DOI?
Copyright
© 2020 Association for Research into Arterial Structure and Physiology. Publishing services by Atlantis Press International B.V.
Open Access
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Cite this article

TY  - JOUR
AU  - Christopher C. Mayer
AU  - Rachel E. Climie
AU  - Bernhard Hametner
AU  - Rosa-Maria Bruno
PY  - 2020
DA  - 2020/05
TI  - The European COST Action VascAgeNet Fostering Innovation – When Industry Comes to Science
JO  - Artery Research
SN  - 1876-4401
UR  - https://doi.org/10.2991/artres.k.200430.001
DO  - https://doi.org/10.2991/artres.k.200430.001
ID  - Mayer2020
ER  -